Jpmorgan Chase & Co »

Innoviva shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Innoviva shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Innoviva

Tip: Access up to 7 years of quarterly data

All positions including Innoviva held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Innoviva by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 2.0M 0.87
2023-09-30 $1.8M 2.2M 0.83
2023-06-30 $284k 343k 0.83
2023-03-31 $515k 657k 0.78

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Innoviva

Wolverine Asset Management
Lazard Asset Management
Highbridge Capital Management
CNH Partners
Calamos Advisors
CSS
Context Capital Management
Capstone Investment Advisors
Russell Investments
Jpmorgan Chase & Co
Daiwa Securities Group
Pinnacle Holdings
SSI Investment Management
Goldman Sachs Group
Citigroup

View all funds holding Innoviva